PAD-IN-2

• CAT Number: I042935
• CAS Number: 2304852-21-7
• Molecular Formula: C27H28ClN5O2
• Molecular Weight: 490.00
• Purity: ≥95%
• Synonyms: [(3R)-3-aminopiperidin-1-yl]-[2-[7-chloro-1-(cyclopropylmethyl)indol-2-yl]-9-oxa-1,3-diazatricyclo[6.3.1.04,12]dodeca-2,4(12),5,7-tetraen-6-yl]methanone
• InChI: InChI=1S/C27H28ClN5O2/c28-20-5-1-3-17-12-22(33(24(17)20)14-16-6-7-16)26-30-21-11-18(13-23-25(21)32(26)9-10-35-23)27(34)31-8-2-4-19(29)15-31/h1,3,5,11-13,16,19H,2,4,6-10,14-15,29H2/t19-/m1/s1
• InChIKey: VWMILHOMRPKNRL-LJQANCHMSA-N
• SMILES: C1C[C@H](CN(C1)C(=O)C2=CC3=C4C(=C2)OCCN4C(=N3)C5=CC6=C(N5CC7CC7)C(=CC=C6)Cl)N

PAD-IN-2（Cat No.:I042935）is a potent and selective inhibitor of peptidylarginine deiminase 4 (PAD4), an enzyme involved in protein citrullination, which plays a key role in autoimmune diseases and cancer progression. By blocking PAD4 activity, PAD-IN-2 prevents excessive citrullination, which is associated with rheumatoid arthritis, multiple sclerosis, and other inflammatory disorders. It also has potential applications in cancer research, where PAD4-mediated chromatin decondensation influences tumor progression. PAD-IN-2 serves as a valuable tool for studying PAD4-related pathways and exploring therapeutic strategies targeting inflammation, autoimmune diseases, and oncology.